Biologics for COPD — Finally Here-Reference-Cited by-同舟云学术

Biologics for COPD — Finally Here

Published:2023-07-20 Issue:3 Volume:389 Page:274-275
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Agusti Alvar¹

Affiliation:

1. From Cátedra de Salud Respiratoria, University of Barcelona, the Respiratory Institute, Hospital Clinic of Barcelona, and the August Pi Sunyer Biomedical Research Institute — all in Barcelona; and Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMe2305752

Reference9 articles.

1. Biologic Therapies for Severe Asthma

2. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

3. Benralizumab for the Prevention of COPD Exacerbations

4. Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment;Proteomes;2024-08-16

2. Unsung Heroes? Decoding the Protective Effects of Airway Microbiota in Chronic Obstructive Pulmonary Disease;American Journal of Respiratory and Critical Care Medicine;2024-07-15

3. Dupilumab for treating chronic obstructive pulmonary disease;Drug and Therapeutics Bulletin;2024-06-19

4. Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease;Respirology;2024-06-11

5. Targeting respiratory microbiomes in COPD and bronchiectasis;Expert Review of Respiratory Medicine;2024-04-02